Gurgaon based Healthtech startup Healthians is aiming to 500 crore revenue with profit and benefits in FY23. But somehow, the company missed to crack the targeted goal and it didn’t arrive at even the midway imprint and significantly its losses spiked 55%.

The Registrar of Companies explained that, The company’s revenue from operation rose up 34.13% to 224 crore in FY23 from 167 crore in FY22.

The company offers wellbeing test at-home services, and has introduced diverse wellbeing tests across 250 urban communities in India. As per the company’s record, it has worked with more than 100 million tests since its origin in 2015.

According to the report of The Kredible, The sale of diagnostics services was the primary source of revenue for Heathians while the rest of the income came from the sale of supplements.

In accordance with comparable healthtech stages, its representative advantages framed 32% of the general use. This cost rose by 83.8% to Rs 136 crore in FY23 from 74 crore in FY22. Its publicizing and special expenses likewise saw an increment of 45% in FY23.

The cost of materials, legal-professional, technical service, information technology, and other overheads increased by 40.9% to 420 crore in FY23 from 298 crore in FY22. The company is further leveraging technology to enhance testing methods and improve customer experience may provide the competitive edge needed to attract and retain clients. The landscape of healthtech industry is propelling  and Healthtech startup Healthians has the ability to adopt more innovative technologies to determine further success.

Read More News :

Mukka Protein's IPO Witnesses Record subscription of 127.67 times on Last Bidding Day

Flipkart, brings you the joy of discovery with in-house UPI system for Seamless Payment